265 related articles for article (PubMed ID: 17115708)
1. The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro.
Nishina KA; Deleault NR; Mahal SP; Baskakov I; Luhrs T; Riek R; Supattapone S
Biochemistry; 2006 Nov; 45(47):14129-39. PubMed ID: 17115708
[TBL] [Abstract][Full Text] [Related]
2. Normal host prion protein necessary for scrapie-induced neurotoxicity.
Brandner S; Isenmann S; Raeber A; Fischer M; Sailer A; Kobayashi Y; Marino S; Weissmann C; Aguzzi A
Nature; 1996 Jan; 379(6563):339-43. PubMed ID: 8552188
[TBL] [Abstract][Full Text] [Related]
3. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity.
Vetrugno V; Cardinale A; Filesi I; Mattei S; Sy MS; Pocchiari M; Biocca S
Biochem Biophys Res Commun; 2005 Dec; 338(4):1791-7. PubMed ID: 16288721
[TBL] [Abstract][Full Text] [Related]
4. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
Iwamaru Y; Shimizu Y; Imamura M; Murayama Y; Endo R; Tagawa Y; Ushiki-Kaku Y; Takenouchi T; Kitani H; Mohri S; Yokoyama T; Okada H
J Neurochem; 2008 Nov; 107(3):636-46. PubMed ID: 18717818
[TBL] [Abstract][Full Text] [Related]
6. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
7. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.
Lucassen R; Nishina K; Supattapone S
Biochemistry; 2003 Apr; 42(14):4127-35. PubMed ID: 12680767
[TBL] [Abstract][Full Text] [Related]
8. Cell-free formation of protease-resistant prion protein.
Kocisko DA; Come JH; Priola SA; Chesebro B; Raymond GJ; Lansbury PT; Caughey B
Nature; 1994 Aug; 370(6489):471-4. PubMed ID: 7913989
[TBL] [Abstract][Full Text] [Related]
9. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
10. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
[TBL] [Abstract][Full Text] [Related]
11. Altered prion protein glycosylation in the aging mouse brain.
Goh AX; Li C; Sy MS; Wong BS
J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation-related gene expression profiling in the brain and spleen of scrapie-affected mouse.
Guillerme-Bosselut F; Forestier L; Jayat-Vignoles C; Vilotte JL; Popa I; Portoukalian J; Le Dur A; Laude H; Julien R; Gallet PF
Glycobiology; 2009 Aug; 19(8):879-89. PubMed ID: 19386898
[TBL] [Abstract][Full Text] [Related]
13. Prion and doppel proteins bind to granule cells of the cerebellum.
Legname G; Nelken P; Guan Z; Kanyo ZF; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16285-90. PubMed ID: 12446843
[TBL] [Abstract][Full Text] [Related]
14. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
15. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
16. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
17. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
Hornemann S; Glockshuber R
J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
[TBL] [Abstract][Full Text] [Related]
18. Prions and exosomes: from PrPc trafficking to PrPsc propagation.
Porto-Carreiro I; Février B; Paquet S; Vilette D; Raposo G
Blood Cells Mol Dis; 2005; 35(2):143-8. PubMed ID: 16099696
[TBL] [Abstract][Full Text] [Related]
19. PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
Khalili-Shirazi A; Summers L; Linehan J; Mallinson G; Anstee D; Hawke S; Jackson GS; Collinge J
J Gen Virol; 2005 Sep; 86(Pt 9):2635-2644. PubMed ID: 16099923
[TBL] [Abstract][Full Text] [Related]
20. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]